An Open-Label Treatment Investigational New Drug (IND) for the Use of Generex Oral-lyn in Patients With Type 1 or Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 19 Mar 2013
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Generex Biotechnology Corporation
- 19 Mar 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 19 Jan 2011 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 05 Aug 2009 New trial record